The EPS beat at Kroger that isn't one

Kroger shares dropped about 3% in early trading on Friday even though the grocery giant reported adjusted earnings of $1.09 a share — better than the $1.06 analysts expected, and up 5% from a year earlier. That looks like a market overreacting to good numbers. It isn't. Look past the headline and the beat is being carried by things that have nothing to do with selling more groceries, while the one number that actually measures demand — identical sales — is crawling near zero.

That is the story in one line: Kroger beat on profit because it got more efficient, and missed on the thing that says whether customers are actually buying. Wall Street read it as a sales problem, and it cut the full-year sales forecast to 0.2%–0.8% growth from its prior 1%–2%.

Two numbers, two different businesses

Identical sales is the metric to understand, because it strips out everything a company can do to make revenue look bigger — new stores, acquisitions, fuel. It compares what existing stores sold against what the same stores sold a year ago. It is the cleanest read on real customer demand, and Kroger's rose just 0.2% in the quarter that ended in mid-August, a collapse from the 3.4% identical growth it posted a year earlier.

Here is the tension the market is pricing. Revenue still grew 2.1% to $34.6 billion, so the top line isn't shrinking. But that growth comes from new space and mix, not from customers buying more at the checkout. Meanwhile the EPS beat was flattered by $1 billion of share buybacks in the quarter — the company has repurchased $1.2 billion this year under a $2 billion authorization — which mechanically shrink the share count and inflate per-share earnings. Buybacks make profit per share look better without adding a single dollar of demand.

The quiet deflation inside a defensive staple

Now the part that should catch the eye of anyone who thinks groceries are immune to the cycle. Kroger laid out 265 basis points of drags on its identical sales: 140 from the Inflation Reduction Act compressing pharmacy dollars as patients shift from branded to cheaper generic drugs, another 60 from that same brand-to-generic switch, 35 from a Cyclospora produce contamination in the final weeks of the quarter, and 30 from falling egg prices. Policy and prices are both deflating the retailer's dollar sales even as customers keep walking through the door.

That is the macro tell. Deflation is not showing up in the headline inflation prints that dominate the news — it is showing up here, in a defensive necessity business. When a grocer selling eggs, fresh produce, and prescriptions can only grow same-store sales by two-tenths of a percent, the U.S. consumer is telling you something about the price of everything and the mood of the person buying it. Management points at cautious shoppers, smaller baskets, SNAP reductions, and fuel above $4 a gallon as the backdrop.

The strategy that explains the miss

This is where the picture stops being simple. New CEO Greg Foran — installed after the collapse of the Albertsons merger last year — is not trying to defend the same-store sales number. His formula, in his own words, is that "savings fund value, earns a trip." The idea: cut sourcing and operating costs, then pour those savings back into lower shelf prices over a multi-year horizon, use value to win the customer's trip, and let share come from the customer, not from the store.

The bets are visible in the margin line. FIFO gross margin actually improved 13 basis points, powered by e-commerce that grew 20% and turned profitable for a second straight quarter after years of losses, plus a retail-media advertising business up 24%. Those are the technology engines working — delivery networks finally crossing breakeven, and the grocer monetizing its customer data like an ad platform. But they are efficiency and mix gains, not demand. And against Walmart and Amazon, which keep winning trips on price and speed, Foran is deliberately trading near-term sales for long-term share. The Giant Eagle deal, a $1.65 billion cash acquisition expected to close in 2027, extends the same play for scale.

Where the risk lives

The uncomfortable arithmetic is the guidance. Kroger cut its full-year identical-sales forecast roughly in half, to 0.2%–0.8%, yet held its profit guidance at $5.10–$5.30 a share, its midpoint in line with what analysts expected. For both to be true, the entire gap must be closed by margin and cost discipline in the back half of the year — exactly when deflationary drags like pharmacy and produce are still pressing down.

That is a gear-shift risk worth weighing. The strategy is coherent only if savings keep coming fast enough to fund ever-deeper price cuts without breaking the profit forecast. If same-store sales stay weak, every dollar earmarked for lower prices is a dollar that must be found again in sourcing, or EPS quietly comes under pressure to subsidize the share grab. In a deflationary, price-war grocery market, the cheapest operator wins — and Kroger is betting its cost base is strong enough to be that operator. The market, cutting the stock on a headline "beat," is betting it can't have it both ways.

The lesson for any cyclical reading applies squarely to a grocery stock: do not take the quality of the earnings at face value when the lead indicator — the demand number that predates the profit arithmetic — is signalling the opposite. The EPS beat was real on its own terms. The sales forecast is the number to watch.